I-TRAF Antibody - #AF5299
製品: | I-TRAF Antibody |
カタログ: | AF5299 |
タンパク質の説明: | Rabbit polyclonal antibody to I-TRAF |
アプリケーション: | WB IF/ICC |
反応性: | Human, Mouse, Rat |
予測: | Pig, Bovine, Horse, Sheep, Rabbit, Dog |
分子量: | 47 kDa; 48kD(Calculated). |
ユニプロット: | Q92844 |
RRID: | AB_2837784 |
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# AF5299, RRID:AB_2837784.
折りたたみ/展開
I TRAF; I-TRAF; ITRAF; Tank; TANK_HUMAN; TRAF family member associated NF KAPPA B activator; TRAF family member associated NFKB activator; TRAF family member-associated NF-kappa-B activator; TRAF interacting protein; TRAF interacting protein TANK isoform a; TRAF interacting protein TANK isoform b; TRAF-interacting protein; TRAF2;
免疫原
- Q92844 TANK_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MDKNIGEQLNKAYEAFRQACMDRDSAVKELQQKTENYEQRIREQQEQLSLQQTIIDKLKSQLLLVNSTQDNNYGCVPLLEDSETRKNNLTLDQPQDKVISGIAREKLPKVRRQEVSSPRKETSARSLGSPLLHERGNIEKTFWDLKEEFHKICMLAKAQKDHLSKLNIPDTATETQCSVPIQCTDKTDKQEALFKPQAKDDINRGAPSITSVTPRGLCRDEEDTSFESLSKFNVKFPPMDNDSTFLHSTPERPGILSPATSEAVCQEKFNMEFRDNPGNFVKTEETLFEIQGIDPIASAIQNLKTTDKTKPSNLVNTCIRTTLDRAACLPPGDHNALYVNSFPLLDPSDAPFPSLDSPGKAIRGPQQPIWKPFPNQDSDSVVLSGTDSELHIPRVCEFCQAVFPPSITSRGDFLRHLNSHFNGET
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - Q92844 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
Ubiquitination | Uniprot | ||
M1 | Acetylation | Uniprot | |
S49 | Phosphorylation | Q14164 (IKBKE) | Uniprot |
K57 | Ubiquitination | Uniprot | |
Y73 | Phosphorylation | Uniprot | |
K86 | Ubiquitination | Uniprot | |
T90 | Phosphorylation | Uniprot | |
K97 | Ubiquitination | Uniprot | |
S100 | Phosphorylation | Q14164 (IKBKE) | Uniprot |
S117 | Phosphorylation | Uniprot | |
S126 | Phosphorylation | Q14164 (IKBKE) | Uniprot |
S129 | Phosphorylation | Uniprot | |
K165 | Ubiquitination | Uniprot | |
T171 | Phosphorylation | Uniprot | |
T175 | Phosphorylation | Uniprot | |
S178 | Phosphorylation | Q14164 (IKBKE) | Uniprot |
K186 | Ubiquitination | Uniprot | |
K189 | Ubiquitination | Uniprot | |
K195 | Ubiquitination | Uniprot | |
K199 | Ubiquitination | Uniprot | |
S208 | Phosphorylation | Q14164 (IKBKE) | Uniprot |
T213 | Phosphorylation | Uniprot | |
S225 | Phosphorylation | Uniprot | |
S228 | Phosphorylation | Q14164 (IKBKE) | Uniprot |
S230 | Phosphorylation | Uniprot | |
K231 | Ubiquitination | Uniprot | |
K235 | Ubiquitination | Uniprot | |
S243 | Phosphorylation | Uniprot | |
T244 | Phosphorylation | Uniprot | |
S248 | Phosphorylation | Uniprot | |
T249 | Phosphorylation | Uniprot | |
S257 | Phosphorylation | Q14164 (IKBKE) | Uniprot |
S261 | Phosphorylation | Uniprot | |
K282 | Ubiquitination | Uniprot | |
K304 | Ubiquitination | Uniprot | |
K308 | Ubiquitination | Uniprot | |
K310 | Ubiquitination | Uniprot | |
Y338 | Phosphorylation | Uniprot | |
S341 | Phosphorylation | Uniprot | |
S354 | Phosphorylation | Uniprot | |
S357 | Phosphorylation | Uniprot | |
K371 | Ubiquitination | Uniprot | |
S380 | Phosphorylation | Uniprot | |
S384 | Phosphorylation | Uniprot | |
S406 | Phosphorylation | Q14164 (IKBKE) | Uniprot |
S409 | Phosphorylation | Q14164 (IKBKE) | Uniprot |
研究背景
Adapter protein involved in I-kappa-B-kinase (IKK) regulation which constitutively binds TBK1 and IKBKE playing a role in antiviral innate immunity. Acts as a regulator of TRAF function by maintaining them in a latent state. Blocks TRAF2 binding to LMP1 and inhibits LMP1-mediated NF-kappa-B activation. Negatively regulates NF-kappaB signaling and cell survival upon DNA damage. Plays a role as an adapter to assemble ZC3H12A, USP10 in a deubiquitination complex which plays a negative feedback response to attenuate NF-kappaB activation through the deubiquitination of IKBKG or TRAF6 in response to interleukin-1-beta (IL1B) stimulation or upon DNA damage. Promotes UBP10-induced deubiquitination of TRAF6 in response to DNA damage. May control negatively TRAF2-mediated NF-kappa-B activation signaled by CD40, TNFR1 and TNFR2.
Phosphorylated by IKBKE.
(Microbial infection) Cleaved by encephalomyocarditis virus (EMCV) protease 3C. This cleavage allows the virus to disrupt the TANK-TBK1-IKKepsilon-IRF3 complex, thereby inhibiting the induction of the IFN-beta signal pathway.
(Microbial infection) Cleaved by Seneca Valley virus protease 3C allowing the virus to suppress interferon type-I through both RIG-I and Toll-like receptor-dependent pathways.
Cytoplasm.
Ubiquitous.
Homodimer. Found in a deubiquitination complex with TANK, USP10 and ZC3H12A; this complex inhibits genotoxic stress- or interleukin-1-beta-mediated NF-kappaB activation by promoting IKBKG or TRAF6 deubiquitination. Interacts with IKBKG; this interaction increases in response to DNA damage. Interacts with TRAF6; this interaction increases in response to DNA damage and recruits USP10 to the ubiquitinated TRAF6. Interacts with USP10; this interaction increases in response to DNA damage. Interacts with ZC3H12A; this interaction increases in response to DNA damage. Interacts with TBK1. Interacts with IKBKE. Interacts also with TRAF1, TRAF2, and TRAF3 by binding to their TRAF-C domains; the interaction with TRAF2 is disrupted by the phosphorylation of TANK by IKBKE. Interacts more strongly with TRAF1 and TRAF2 than TRAF3. Interacts with IKBKG; the interaction is enhanced by IKBKE and TBK1. Part of a ternary complex consisting of TANK, IKBKB and IKBKG.
(Microbial infection) Interacts with vaccinia virus protein C6.
(Microbial infection) Interacts with Seneca Valley virus protease 3C; this interaction allows the cleavage of TANK and subsequent suppression of host innate immunity.
研究領域
· Organismal Systems > Immune system > NOD-like receptor signaling pathway. (View pathway)
· Organismal Systems > Immune system > RIG-I-like receptor signaling pathway. (View pathway)
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.